PL361881A1 - Sposoby wytwarzania na dużą skalę cząsteczek tPA lub K2S pochodzących z rekombinowanego DNA - Google Patents

Sposoby wytwarzania na dużą skalę cząsteczek tPA lub K2S pochodzących z rekombinowanego DNA

Info

Publication number
PL361881A1
PL361881A1 PL36188101A PL36188101A PL361881A1 PL 361881 A1 PL361881 A1 PL 361881A1 PL 36188101 A PL36188101 A PL 36188101A PL 36188101 A PL36188101 A PL 36188101A PL 361881 A1 PL361881 A1 PL 361881A1
Authority
PL
Poland
Prior art keywords
molecules
methods
recombinant dna
large scale
scale production
Prior art date
Application number
PL36188101A
Other languages
English (en)
Other versions
PL206783B1 (pl
Inventor
Rolf-Günther Werner
Friedrich Goetz
Chatchai Tayapiwatana
Jiradej Manosroi
Aranya Manosroi
Original Assignee
Boehringer Ingelheim International Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim International Gmbh filed Critical Boehringer Ingelheim International Gmbh
Publication of PL361881A1 publication Critical patent/PL361881A1/pl
Publication of PL206783B1 publication Critical patent/PL206783B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
PL361881A 2000-11-14 2001-11-07 Sposób wytwarzania rekombinowanego tkankowego aktywatora plazminogenu tPA lub cząsteczki K2S, cząsteczka DNA, białka fuzyjne, wektor, komórka gospodarza i ich zastosowanie PL206783B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0027779.8A GB0027779D0 (en) 2000-11-14 2000-11-14 Methods for large scale production of recombinant dna-derived tpa or k2s molecules
PCT/EP2001/012857 WO2002040650A2 (en) 2000-11-14 2001-11-07 Methods for large scale production of recombinant dna-derived tpa or k2s molecules

Publications (2)

Publication Number Publication Date
PL361881A1 true PL361881A1 (pl) 2004-10-04
PL206783B1 PL206783B1 (pl) 2010-09-30

Family

ID=9903153

Family Applications (1)

Application Number Title Priority Date Filing Date
PL361881A PL206783B1 (pl) 2000-11-14 2001-11-07 Sposób wytwarzania rekombinowanego tkankowego aktywatora plazminogenu tPA lub cząsteczki K2S, cząsteczka DNA, białka fuzyjne, wektor, komórka gospodarza i ich zastosowanie

Country Status (31)

Country Link
EP (1) EP1407030B1 (pl)
JP (1) JP2004520018A (pl)
KR (1) KR100856346B1 (pl)
CN (1) CN100567495C (pl)
AR (1) AR031334A1 (pl)
AT (1) ATE504652T1 (pl)
AU (2) AU2002221815B2 (pl)
BG (1) BG66121B1 (pl)
BR (1) BR0115344A (pl)
CA (1) CA2428642C (pl)
CZ (1) CZ20031657A3 (pl)
DE (1) DE60144395D1 (pl)
EA (1) EA005163B1 (pl)
EC (1) ECSP034573A (pl)
EE (1) EE200300232A (pl)
GB (1) GB0027779D0 (pl)
HR (1) HRP20030377A2 (pl)
HU (1) HUP0301619A3 (pl)
IL (2) IL155568A0 (pl)
MX (1) MXPA03004161A (pl)
MY (1) MY129838A (pl)
NO (1) NO20032143L (pl)
NZ (1) NZ526280A (pl)
PL (1) PL206783B1 (pl)
SK (1) SK5792003A3 (pl)
TW (1) TWI292782B (pl)
UA (1) UA75102C2 (pl)
UY (1) UY27020A1 (pl)
WO (1) WO2002040650A2 (pl)
YU (1) YU36103A (pl)
ZA (1) ZA200303547B (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6955910B2 (en) 2000-11-14 2005-10-18 Boehringer Ingelheim International Gmbh Method for large scale production of recombinant DNA-derived TPA or K2S molecules
US7087412B2 (en) 2000-11-14 2006-08-08 Boehringer Ingelheim International Gmbh Methods for large scale protein production in prokaryotes
IL190184A0 (en) * 2008-03-16 2009-02-11 Hadasit Med Res Service tPA MUTANT IN THE TREATMENT OF ACUTE BRAIN INJURY AND NEURODEGENERATIVE DISORDERS

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL87276A (en) * 1987-08-03 1995-07-31 Fujisawa Pharmaceutical Co Analog of tissue plasminogen activator comprising only the kringle 2 and protease domain dna encoding the same processes for the preparation thereof and pharmaceutical compositions containing the same
AU2660397A (en) * 1996-04-05 1997-10-29 Board Of Regents, The University Of Texas System Methods for producing soluble, biologically-active disulfide bond-containing eukaryotic proteins in bacterial cells
US20020061576A1 (en) * 1997-05-28 2002-05-23 Paul A. Moore Tissue plasminogen activator-like protease
US6083715A (en) * 1997-06-09 2000-07-04 Board Of Regents, The University Of Texas System Methods for producing heterologous disulfide bond-containing polypeptides in bacterial cells
EP1048732A1 (de) * 1999-04-26 2000-11-02 F. Hoffmann-La Roche Ag Verfahren zur Herstellung von natürlich gefalteten und sekretierten Proteinen
EP1077263A1 (de) * 1999-07-29 2001-02-21 F.Hoffmann-La Roche Ag Verfahren zur Herstellung von natürlich gefalteten und sekretierten Proteinen durch Co-Sekretion von Chaperonen
GB0027782D0 (en) * 2000-11-14 2000-12-27 Boehringer Ingelheim Int Methods fro large scale protein productio in prokaryotes

Also Published As

Publication number Publication date
CN100567495C (zh) 2009-12-09
AU2181502A (en) 2002-05-27
BG66121B1 (bg) 2011-05-31
UA75102C2 (en) 2006-03-15
TWI292782B (en) 2008-01-21
IL155568A0 (en) 2003-11-23
HUP0301619A3 (en) 2006-11-28
AU2002221815B2 (en) 2007-08-23
MXPA03004161A (es) 2004-04-20
NO20032143D0 (no) 2003-05-13
WO2002040650A2 (en) 2002-05-23
MY129838A (en) 2007-05-31
SK5792003A3 (en) 2004-01-08
NO20032143L (no) 2003-07-07
CA2428642C (en) 2010-03-30
DE60144395D1 (de) 2011-05-19
PL206783B1 (pl) 2010-09-30
CZ20031657A3 (cs) 2003-10-15
KR20030059252A (ko) 2003-07-07
NZ526280A (en) 2006-02-24
BR0115344A (pt) 2003-08-26
AR031334A1 (es) 2003-09-17
IL155568A (en) 2010-02-17
GB0027779D0 (en) 2000-12-27
HUP0301619A2 (hu) 2003-09-29
EE200300232A (et) 2003-10-15
ZA200303547B (en) 2004-05-10
EA200300502A1 (ru) 2003-12-25
CA2428642A1 (en) 2002-05-23
EP1407030B1 (en) 2011-04-06
KR100856346B1 (ko) 2008-09-04
HRP20030377A2 (en) 2005-04-30
ECSP034573A (es) 2003-05-26
EA005163B1 (ru) 2004-12-30
BG107780A (bg) 2004-02-27
YU36103A (sh) 2006-05-25
WO2002040650A3 (en) 2003-12-31
ATE504652T1 (de) 2011-04-15
EP1407030A2 (en) 2004-04-14
UY27020A1 (es) 2002-07-31
HK1070097A1 (zh) 2005-06-10
CN1541271A (zh) 2004-10-27
JP2004520018A (ja) 2004-07-08

Similar Documents

Publication Publication Date Title
AU2002239504A1 (en) Laboratory scale milling process
DE60139122D1 (de) Verfahren zur produktion von natürlichen medizin präparaten
AU2001271669A1 (en) Multipartite high-affinity nucleic acid probes
PT1293507E (pt) Processo para produção de cristais
AU4941101A (en) Novel prostate-specific or testis-specific nucleic acid molecules, polypeptides,and diagnostic and therapeutic methods
AU2001243670A1 (en) Method for generating recombinant dna molecules in complex mixtures
IL149846A0 (en) Method for obtaining nucleic acids from an evironment sample, resulting nucleic acids and use in synthesis of novel compounds
EP1339875A4 (en) COMPOSITIONS AND METHOD FOR THE FAST PRODUCTION OF RECOMBINANT NUCLEIC ACID MOLECULES
DE60123308D1 (de) Glaswerkstoff, glaskeramisches Produkt, und Verfahren zur Herstellung des Glaswerkstoffes
AU2001244609A1 (en) Novel protein, dna thereof and process for producing the same
NO20011195L (no) System og fremgangsmate for raffinormalinger
AU2001287392A1 (en) Insulated formwork panels and process for their manufacture
AU2002367943A8 (en) Improved reagents and methods for producing parvoviruses
HUP0303377A3 (en) Method for the detection of nucleic acid molecules
AU2002221824A1 (en) Methods for large scale protein production in prokaryotes
GB0027779D0 (en) Methods for large scale production of recombinant dna-derived tpa or k2s molecules
HU0104565D0 (en) Process for production of linalool-oxyde or mixtures containing thereof
EP1425289A4 (en) NOVEL NUCLEIC ACID AND POLYPEPTIDE MOLECULES
EP1366360A4 (en) PROCESS FOR PROTEIN COMPARISON IN THE LARGE RANGE
IL153601A0 (en) Cyanobacterial nucleic acid fragments encoding proteins useful for controlling plant traits via nuclear or plastome transformation
AU2001256585A1 (en) Method for constructing, representing or displaying protein interaction maps
FI982367L (fi) Menetelmä käyttökelpoisten tuotteiden valmistamiseksi epäpuhtaasta ferrisulfaattiliuoksesta
AU2001276782A1 (en) Process for the recovery of rhodium
AU2001249929A1 (en) Fdrg proteins and nucleic acid molecules and uses therefor
AU2002239529A1 (en) Prostate-specific polypeptide pamp and encoding nucleic acid molecules

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20111107